A study of analyst recommendations at the major brokerages shows that Commercial Metals Co. (CMC - Get Report) is the #38 broker analyst pick, on average, out of the 50 stocks making up the Metals Channel Global Mining Titans Index, according to Metals Channel. The Metals Channel Global Mining Titans Index is comprised of the top fifty global leaders from the metals and mining sector. The companies listed in the Metals Channel Global Mining Titans Index are not fixed, but instead variable — updating on a continuous basis to reflect the changing market environment with respect to commodity prices, government policy and market volatility.In forming this rank, the analyst opinions from the major brokerage houses were tallied, and averaged; then, the underlying components of the Metals Channel Global Mining Titans Index were ranked according to those averages. Investors often interpret analyst opinions from different angles — when companies have a low rank among analysts, it isn't necessarily the case that investors should conclude that the stock will perform poorly. It can, of course, but a bullish investor could also take the contrarian angle and read into the data that there is lots of room for upside because the stock is so out of favor. From the other direction, a popular analyst pick could mean that many sharp minds individually came to the same bullish conclusion, and therefore the stock should do well, but it could also mean that if the company stumbles, that would come as a negative surprise. According to the ETF Finder at ETF Channel, CMC makes up 4.49% of the SPDR S&P Metals & Mining ETF (XME) which is trading higher by about 1.8% on the day Thursday. CMC operates in the Non-Precious Metals & Non-Metallic Mining sector, among companies like Ternium S A (TX) which is up about 1.2% today, and Vale SA (VALE) trading higher by about 0.8%. Below is a three month price history chart comparing the stock performance of CMC, versus TX and VALE. CMC is currently trading up about 1.8% midday Thursday.
More from Stocks
A Pair of Rare Disease Biotech Concerns Worth a Good Look
Alexion Pharmaceuticals is a solid company that is the subject of acquisition rumors and Amicus Therapeutics has a key drug off to a strong start.
What's the Difference Between Monetary and Fiscal Policy?
It's all about interest rates and taxes for people and businesses.
Facebook Knew of Potential Cambridge Analytica Issues as Early as Sept. 2015
Internal documents show Facebook employees knew that Cambridge was potentially misusing user data earlier than previously thought. Facebook says there were two separate incidents, however.
Stocks Fall as China Announces Tariffs Ahead of Speech From Fed Chief Powell
Stocks are falling Friday after China said it would take retaliatory measures in its tariff battle with the U.S. and Wall Street awaited a scheduled address from Federal Reserve Chairman Jerome Powell.